Lycia Therapeutics Inc.
Status: Publicly traded
Last reviewed: November 2026
Direct answer
Lycia Therapeutics Inc. is publicly traded on NASDAQ under the ticker LYCA.
Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.
Can you invest in Lycia Therapeutics Inc.?
Yes. Lycia Therapeutics Inc. is publicly traded on NASDAQ under the ticker LYCA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lycia Therapeutics Inc.
Detailed equity research is provided by MarketSnap.